Labcorp Holdings (LH) Cost of Revenue (2009 - 2026)

Labcorp Holdings has disclosed Cost of Revenue across 18 years of filings, most recently posting $2.6 billion for Q2 2026.

• In Q2 2026, Cost of Revenue rose 5.56% year-over-year to $2.6 billion; the TTM figure through Jun 2026 stood at $10.2 billion (up 5.32% YoY), while the FY2025 annual figure was $9.9 billion, up 5.91% from the prior year.
• Cost of Revenue came in at $2.6 billion for Q2 2026 at Labcorp Holdings, up from $2.5 billion in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $2.7 billion in Q1 2022 to a low of $2.0 billion in Q2 2022.
• Average Cost of Revenue over 5 years is $2.3 billion, with a median of $2.3 billion recorded in 2024.
• The largest YoY upside for Cost of Revenue was 549.48% in 2022 against a maximum downside of 26.02% in 2022.
• Over 5 years, Cost of Revenue stood at $2.1 billion in 2022, then gained by 3.77% to $2.2 billion in 2023, then grew by 10.0% to $2.4 billion in 2024, then gained by 3.68% to $2.5 billion in 2025, then rose by 3.83% to $2.6 billion in 2026.
• Per Business Quant data, the three most recent Cost of Revenue figures were $2.6 billion in Q2 2026, $2.5 billion in Q1 2026, and $2.5 billion in Q4 2025.